INTS
NASDAQ · Biotechnology
Intensity Therapeutics Inc
$3.10
-0.18 (-5.49%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,093.5% upside
Low Target
$31.85
Average Target
$37.00
High Target
$43.82
Current Price
$3.10
Current
$3.10
$3.10
Target
$37.00
$37.00
$31.85
$37.00 avg
$43.82
Scenario Analysis
Bear Case
$31.85
927.4%
Low target
Base Case
$37.00
+1,093.5%
Avg target
Bull Case
$43.82
+1,313.5%
High target
Risk/Reward
1.4x
Balanced
Price in Context
52-Week High
$15.75
-80.3% from high
52-Week Low
$2.80
+10.7% from low
Target vs 52W High
$37.00
+134.9% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.5% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |